CXCR4 and ductal breast carcinoma in situ: Moreover, the expression of CXCR4, the CXCL12 receptor is elevated in invasive tumors compared to both DCIS and normal tissue, lending support to the idea that increased chemokine signaling contributes to DCIS progression [100].